Does Oral Desogestrel Prior to Insertion of the Etonogestrel Subdermal Implant Improve Continuation Rate at One Year?

NCT05174195 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

67

Enrollment

OTHER

Sponsor class

Stopped difficult recruitment

Conditions

Contraception
Progestogen Adverse Reaction

Interventions

DRUG: Desogestrel 0.075 milligram
DRUG: Implanon NXT® subdermal implant

Sponsor

University Hospital, Geneva